The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11466
DOI: 10.3390/ijms252111466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Urszula Oleksiewicz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Histones, Epigenesis, Genetic. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland.
Abstract (Originalsprache)
The interplay between cancer and the immune system has captivated researchers for a long time. Recent developments in cancer immunotherapy have substantiated this interest with a significant benefit to cancer patients. Tumor and immune cells are regulated via a wide range of molecular mechanisms involving intricate transcriptional and epigenetic networks. Epigenetic processes influence chromatin structure and accessibility, thus governing gene expression, replication, and DNA damage repair. However, aberrations within epigenetic signatures are frequently observed in cancer. One of the key epigenetic marks is the trimethylation of histone 3 at lysine 9 (H3K9me3), confined mainly within constitutive heterochromatin to suppress DNA accessibility. It is deposited at repetitive elements, centromeric and telomeric loci, as well as at the promoters of various genes. Dysregulated H3K9me3 deposition disrupts multiple pathways, including immune signaling. Consequently, altered H3K9me3 dynamics may modify the efficacy of immunotherapy. Indeed, growing evidence highlights the pivotal roles of various proteins mediating H3K9me3 deposition (SETDB1/2, SUV39H1/2), erasure (KDM3, KDM4 families, KDM7B, LSD1) and interpretation (HP1 proteins, KAP1, CHD4, CDYL, UHRF1) in modulating immunotherapy effectiveness. Here, we review the existing literature to synthesize the available information on the influence of these H3K9me3 writers, erasers, and readers on the response to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
- Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Center, 61-866 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
- Faculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland.
- Department of Health Sciences, The Jacob of Paradies University, 66-400 Gorzow Wielkopolski, Poland.
ORCID-Profile: Urszula Oleksiewicz, Monika Kuciak, Justyna Sadowska, Patrycja Czerwinska, Andrzej A Mackiewicz
Förderung
- National Science Centre, Poland
Zitieren
APA
Oleksiewicz, U., Kuciak, M., Jaworska, A., Adamczak, D., Bisok, A., Mierzejewska, J., Sadowska, J., Czerwinska, P., & Mackiewicz, A. A. (2024). The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy. International Journal of Molecular Sciences, 25(21), 11466. https://doi.org/10.3390/ijms252111466
Vancouver
Oleksiewicz U, Kuciak M, Jaworska A, Adamczak D, Bisok A, Mierzejewska J, et al. The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy. International Journal of Molecular Sciences. 2024;25(21):11466. doi:10.3390/ijms252111466
BibTeX
@article{Oleksiewicz2024,
author = {Oleksiewicz, Urszula and Kuciak, Monika and Jaworska, Anna and Adamczak, Dominika and Bisok, Anna and Mierzejewska, Julia and Sadowska, Justyna and Czerwinska, Patrycja and Mackiewicz, Andrzej A},
title = {The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11466},
doi = {10.3390/ijms252111466}
}
EUVIMED